Deadline for submission of nominations
September 15, 2010
The ASPET-Astellas Awards in Translational Pharmacology are intended to extend fundamental research closer to applications directed towards improving human health. The awards will be given to 1) recognize those individuals whose research has the potential to lead to the introduction of novel pharmacologic approaches or technologies that may offer significant advances in clinical medicine in the future and 2) to facilitate that translational process. The awards are made possible by a grant to ASPET from the Astellas Foundation.
Three (3) awards of $30,000 each will be made to individuals. The money may be used for supplemental research funding, travel, training, or in any way that furthers the goals described above. In addition to the $30,000, award winners will receive travel to and lodging at the ASPET annual meeting for the winner and his/her spouse.
There are no restrictions on nominees for this award. Any ASPET member in good standing may nominate an individual for this award. Selection of the recipients will be made by a committee, appointed by the President of ASPET and comprised of current and former Council members and current Division Chairs. Awards will be judged in two categories, viz. junior and senior investigators, with at least one award being given in each category. Junior investigators are defined as individuals at the assistant professor or equivalent level. In the event that there are insufficient meritorious candidates in either the junior or senior category, the committee reserves the right to make all awards in a single category. Self-nominations will not be accepted. The nominations shall be judged on submitted information and take into account:
- The publication record of the applicant;
- The quality and impact of the published research cited in support of the award nomination;
- The potential of the proposed studies to advance clinical medicine through the introduction of novel pharmacological approaches to therapeutics;
- The feasibility of the proposed research given the size of the award; and
- The applicant's current funding to support the proposed project. For junior
investigators, institutional commitment may also be a consideration.
Nominations shall be submitted electronically to jane.nelson@aspet.org and shall consist of:
- A two-page summary that details the importance of the candidate’s work and how it meets the criteria of the award;
- Two additional supporting letters (need not be from ASPET members);
- Candidate’s CV and bibliography;
- A two-page statement from the candidate of his/her plans for moving his/her research toward clinical practice and how the award money would be used to further this goal; and
- Up to 5 articles published or submitted for publication (either PDFs or links
to the articles may be submitted).
The receipt date for nominations for the ASPET-Astellas Awards is September
15, 2010 for awards to be presented at Experimental Biology ’11 in Washington, DC. Award winners will be notified in January 2011.
Recipients of the ASPET-Astellas Award in Translational Pharmacology
P. Jeffrey Conn - 2007
Kathryn A. Cunningham - 2007
Liewei Wang - 2007
Randy D. Blakely - 2008
Anthony J. Kanai - 2008
John S. Lazo - 2008
Piyali Dasgupta - 2009
Paul A. Insel - 2009
Richard R. Neubig - 2009
Craig W. Lindsley - 2010
Kenneth D. Tew - 2010
Gonzalo F. Torres - 2010